779 A phase 1/2, open label, first-in-human, dose escalation and expansion study of SAR445877 administered as monotherapy in adults with advanced solid tumors
Journal for ImmunoTherapy of Cancer(2023)
关键词
sar445877,advanced solid tumors,solid tumors,monotherapy,first-in-human
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要